Although its package insert has specific dose reduction criteria, providers may dose reduce outside of these parameters based on clinical scenarios. Objective: The primary objective was to determine the incidence of apixaban off-label reduced dosing, while secondarily determining the safety and efficacy...
What is known and objectives:Although the apixaban Food and Drug Administration (FDA) package insert recommends dose reduction in patients administered dua... E Milner,M Ainsworth,M Gleaton,... - 《Journal of Clinical Pharmacy & Therapeutics》 被引量: 0发表: 2022年 Apixaban plasma concentrations...